{
  "ticker": "ALA",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969679",
  "id": "02969679",
  "pages": 6,
  "price_sensitive": false,
  "date": "20250716",
  "time": "0854",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lv305c1tft8z.pdf",
  "summary": "### **ASX Announcement Summary**  \n**Document Type:** Appendix 3G \u2013 Notification of issue of unquoted equity securities  \n**Entity:** AROVELLA THERAPEUTICS LIMITED (ASX: ALA)  \n\n#### **Material Information:**  \n- **1.5 million unquoted options (ALAAA)** issued on **15/07/2025** with:  \n  - Exercise price: **$0.1439**  \n  - Expiry date: **7 July 2029**.  \n- **No issue to KMPs** (key management personnel).  \n- Total unquoted ALAAA options on issue after this issuance: **67,403,770**.  \n- Issued under **Listing Rule 7.2 exception 13** (no shareholder approval required).  \n\n**No other material trading or capital markets impacts identified.**  \n\n*(Omitted: Standard issuance terms, ASX code updates, and non-material operational details.)*",
  "usage": {
    "prompt_tokens": 1454,
    "completion_tokens": 200,
    "total_tokens": 1654,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-15T23:17:46.225650"
}